Discontinuation of Dolutegravir, EVG/c and Raltegravir Discontinuation of Dolutegravir, EVG/c and Raltegravir

A new study examines the discontinuation rates among these integrase inhibitor regimens due to neuropsychiatric adverse events.HIV Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news